Studying the Progression of Amyloid Pathology and Its Therapy Using Translational Longitudinal Model of Accumulation and Distribution of Amyloid Beta
Author:
Affiliation:
1. InSysBio; Moscow Russia
2. Pfizer; Cambridge MA USA
3. Pfizer; Groton CT USA
Publisher
Wiley
Subject
Pharmacology (medical),Modelling and Simulation
Reference46 articles.
1. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein;Selkoe;Ann. NY Acad. Sci.,2000
2. In vitro characterization of conditions for amyloid-betqa peptide oligomerization and fibrillogenesis;Stine;J. Biol. Chem.,2003
3. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging;Wang;Exp. Neurol.,1999
4. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans;Fagan;Ann. Neurol.,2006
5. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study;Villemagne;Lancet Neurol.,2013
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using Quantitative Systems Pharmacology Model;Drugs;2024-06-20
2. An industry perspective on current QSP trends in drug development;Journal of Pharmacokinetics and Pharmacodynamics;2024-03-05
3. A combined physiologically‐based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease;CPT: Pharmacometrics & Systems Pharmacology;2023-01-20
4. Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates;CPT: Pharmacometrics & Systems Pharmacology;2022-11-06
5. Patients with Alzheimer’s disease have an increased removal rate of soluble beta-amyloid-42;PLOS ONE;2022-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3